Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Kissing Many Frogs: A Grimm Tale or Necessary Reality When Precision Fundraising in Biotech is Out of Reach?

The future of biotech fundraising may not belong to companies that pitch to the most investors. It will more likely belong to those that understand which investors are most likely to become long-term partners and how to navigate to them efficiently. In fundraising, as in medicine, precision is beating trial and error.  

 

Refining the Molecular Blueprint of In Vivo CAR-T Cell Therapies

*Guest blog by Lab Thread. If you would like to submit a guest blog please email [email protected].


Following the first commercial approvals in 2017, the chimeric antigen receptor (CAR) T-cell therapy market has expanded rapidly thanks to the significant impact these treatments have had on patient outcomes in hematologic cancers, and is projected to keep growing as CAR T-cell therapies are administered earlier in the patient’s treatment journey, and target indications expand from oncology into autoimmune conditions.

Qureight Closes $20 million Series B Financing

  • Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension
  • Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further accelerate clinical trials in lung fibrosis
  • Building a state of the art AI imaging laboratory will allow Qureight to move rapidly into new lung and heart diseases including asthma, pulmonary hypertension and bronchiectasis

Research Scientist

The Quadram Institute is a cutting-edge £75 million facility with strategic research programmes in Food, Microbiome and Health, and Microbes and Food Safety.   We bring together a diverse team of researchers, academics, and NHS clinicians to tackle pressing issues in human health, food, and disease. Our innovative approach bridges food science, gut biology, and human health, leveraging the world-class bioscience cluster at Norwich Research Park.

The role:

Research Assistant in AI for Medical Imaging

Applications are invited for a Research Assistant to join a highly successful multidisciplinary collaboration between the groups of Dr Mireia Crispin and Dr Matt Hoare at the Early Cancer Institute, located on the Cambridge Biomedical Campus. Working at the interface of artificial intelligence, data science and cancer research, this work will develop next-generation computational methods to improve early liver cancer detection and accurately predict malignancy risk.

Human Resources Director

Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.

As we continue to evolve the Institute we are seeking a Human Resources Director to lead the next phase of our People strategy, partnering with the Chief Operating Officer, Executive Senior Leadership Team and Wellcome to ensure our people strategy enables the Institute to deliver its ambitious scientific mission. 

EA / Office Manager

We’re looking for a highly organised, personable EA/Office Manager to keep the Leadership Team efficient and the office running smoothly.

This role combines executive support with office and operations management – ideal for a person who thrives on building relationships, bringing order to chaos, and delivering value across the business.

Project Manager (AI models)

About us

Qureight’s mission is toaccelerate clinical trials and ensure breakthroughs in lung and heart disease reach patients without delay. Our AI-powered data and imaging curation platform enables the analysis of clinical imaging and other healthcare data, helping our customers bring treatments to market, faster.